3Montague D K, Barada J H, Belker A M, et al. Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction[J]. J Urol, 1996, 156(6) :2007 - 2011.
4Maneeke R G, Mulhal] J P. Trends in clinical practice: medical treatment of erectile dysfunction [J]. Ann Med, 1999,31 : 388 - 398.
5Moreland R B, Nakane M, Hsieh A, et al. Prospective for pharmacotherapy of male erectile dysfunction[ J]. Curr Opin CPNS Invest Drug, 2000,2(3) :283 - 302.
6Padma-Nathan H, Hellstrom W J G, Kaiser F E, et al. Treat-ment of men with erectile dysfunction with transurethral alprostadil[J]. N Engl J Med, 1997,337(1):1-7.
7Engel J D, Mcvary K T. Transurethral alprostadil as therapy for patients who withdrew from of failed prior intracavemous injection therapy [J].Urology, 1998,51(5) :687 - 692.
8Fulgham P F, Cochran J S, Denman J L, et al. Disappointing initial results with transttrethcal alprostadil for erectile dysfimction in a urology practice setting[J]. J Urol, 1998,160(6) :2041 - 2046.
